Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Kronos Bio Q4 2024 GAAP EPS $(0.43) Misses $(0.38) Estimate, Sales $2.270M Miss $2.420M Estimate

Author: Benzinga Newsdesk | March 18, 2025 04:03pm
Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.38) by 13.16 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.270 million which missed the analyst consensus estimate of $2.420 million by 6.20 percent. This is a 0.70 percent decrease over sales of $2.286 million the same period last year.

Posted In: KRON


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist